Post Inflammatory Hyperpigmentation Completed Phase 4 Trials for Benzoyl peroxide (DB09096)

Also known as: Post inflammatory pigmentation change / Postinflammatory hyperpigmentation

IndicationStatusPhase
DBCOND0045798 (Post Inflammatory Hyperpigmentation)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03402893The Use of Onexton in Moderate Acne Vulgaris for Patients With Skin of ColorTreatment